DK1047704T3 - Fremgangsmåde til fremstilling af lithium-, kalium-, calcium- og magnesiumsalte af fludarabin-phosphat og rensningsfremgangsmåde til fremstilling af fludarabin-phosphat og fludarabin-phosphat med en renhed på mindst 99,5% - Google Patents

Fremgangsmåde til fremstilling af lithium-, kalium-, calcium- og magnesiumsalte af fludarabin-phosphat og rensningsfremgangsmåde til fremstilling af fludarabin-phosphat og fludarabin-phosphat med en renhed på mindst 99,5%

Info

Publication number
DK1047704T3
DK1047704T3 DK98965703T DK98965703T DK1047704T3 DK 1047704 T3 DK1047704 T3 DK 1047704T3 DK 98965703 T DK98965703 T DK 98965703T DK 98965703 T DK98965703 T DK 98965703T DK 1047704 T3 DK1047704 T3 DK 1047704T3
Authority
DK
Denmark
Prior art keywords
fludarabine phosphate
purity
lithium
potassium
calcium
Prior art date
Application number
DK98965703T
Other languages
English (en)
Other versions
DK1047704T4 (da
Inventor
Ulf Tilstam
Klaus Nickisch
Thomas Schmitz
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7852365&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1047704(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Ag filed Critical Schering Ag
Application granted granted Critical
Publication of DK1047704T3 publication Critical patent/DK1047704T3/da
Publication of DK1047704T4 publication Critical patent/DK1047704T4/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/19—Purine radicals with arabinosyl as the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK98965703T 1997-12-11 1998-11-30 Fremgangsmåde til fremstilling af lithium-, kalium-, calcium- og magnesiumsalte af fludarabin-phosphat og rensningsfremgangsmåde til fremstilling af fludarabin-phosphat og fludarabin-phosphat med en renhed på mindst 99,5% DK1047704T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19756289 1997-12-11
PCT/EP1998/007651 WO1999029710A2 (de) 1997-12-11 1998-11-30 Reinigungsverfahren zur herstellung von fludarabin-phosphat

Publications (2)

Publication Number Publication Date
DK1047704T3 true DK1047704T3 (da) 2003-06-23
DK1047704T4 DK1047704T4 (da) 2008-03-25

Family

ID=7852365

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98965703T DK1047704T4 (da) 1997-12-11 1998-11-30 Fremgangsmåde til fremstilling af lithium-, kalium-, calcium- og magnesiumsalte af fludarabin-phosphat og rensningsfremgangsmåde til fremstilling af fludarabin-phosphat og fludarabin-phosphat med en renhed på mindst 99,5%

Country Status (21)

Country Link
US (2) US6046322A (da)
EP (1) EP1047704B2 (da)
JP (2) JP4261051B2 (da)
KR (2) KR20050085937A (da)
AT (2) ATE231880T1 (da)
AU (1) AU739574B2 (da)
CA (1) CA2313486A1 (da)
CZ (1) CZ296366B6 (da)
DE (2) DE59807096D1 (da)
DK (1) DK1047704T4 (da)
ES (1) ES2190136T5 (da)
HK (1) HK1033831A1 (da)
HU (1) HU226997B1 (da)
IL (1) IL136283A (da)
NO (1) NO315324B1 (da)
PL (1) PL195712B1 (da)
SI (1) SI1047704T2 (da)
SK (1) SK283475B6 (da)
TW (1) TW424093B (da)
WO (1) WO1999029710A2 (da)
ZA (1) ZA9811338B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2313486A1 (en) 1997-12-11 1999-06-17 Schering Aktiengesellschaft Purification method for producing fludarabin phosphate
KR100381930B1 (ko) * 2000-03-16 2003-04-26 (주)바이오니아 유전자 변형 농산물 검출방법 및 검출용 프라이머
WO2003049763A1 (en) 2001-12-12 2003-06-19 Fh Faulding & Co Limited Composition for the preservation of viruses
DE10164510A1 (de) * 2001-12-20 2003-07-10 Schering Ag Orale Fludara reinst Formulierung mit schneller Freisetzung des Wirkstoffes
EP1542531A4 (en) * 2002-05-24 2011-01-05 Sicor Inc Aqueous fludarabine phosphorus composition
EP1464708A1 (en) * 2003-04-03 2004-10-06 Pro. Bio. Sint. S.p.A. A process for the preparation of fludarabine phosphate from 2-fluoroadenine
US7698201B2 (en) * 2006-09-14 2010-04-13 The Prudential Insurance Company Of America Financial instrument utilizing an optional benefit election
CN103040855B (zh) * 2012-12-28 2014-05-14 海南锦瑞制药股份有限公司 一种磷酸氟达拉滨的药物组合物及其制备方法
CN107922456A (zh) * 2015-08-28 2018-04-17 浙江海正药业股份有限公司 磷酸氟达拉滨的晶型及其制备方法和用途
CN109265505A (zh) * 2018-09-12 2019-01-25 连云港杰瑞药业有限公司 一种磷酸氟达拉滨异构体杂质的合成方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE756704A (fr) 1969-09-26 1971-03-01 Parke Davis & Co Procede de production du 5'-phosphate de 9-(beta-d- arabinofuranosyl) adenine et de ses sels
US4188378A (en) * 1978-01-04 1980-02-12 The United States Of America As Represented By The Department Of Health, Education And Welfare Anticancer and antiviral activity of 9-β-D-arabinofuranosyl-2-fluoroadenine
US4210745A (en) * 1978-01-04 1980-07-01 The United States Of America As Represented By The Department Of Health, Education And Welfare Procedure for the preparation of 9-β-D-arabinofuranosyl-2-fluoroadenine
US4357324A (en) * 1981-02-24 1982-11-02 The United States Of America As Represented By The Department Of Health And Human Services Prodrug derivatives of 9β-D-arabinofuranosyl-2-fluoroadenine
DE3323621A1 (de) 1982-07-08 1984-03-01 Yamasa Shoyu K.K., Choshi, Chiba Pharmazeutisches praeparat mit die antitumor-wirkung verstaerkender wirkung, ein solches praeparat enthaltende chemotherapeutische zusammensetzung und verwendung des praeparates zur unterstuetzung der antitumor-behandlung beim menschen und tier
US5110919A (en) * 1989-12-04 1992-05-05 Ash Stevens, Inc. Process for the preparation of 2-amino-9-(2,3,5-tri-o-benzyl-beta-d-arabinofuranosyl) adenine and novel intermediates
DK0487719T3 (da) * 1990-06-27 1999-05-17 Ash Stevens Inc Fremgangsmåde til fremstilling af 9-beta-D-arabinofuranosyl-2-fluoradenin-5'-phosphat
US5602246A (en) 1992-11-25 1997-02-11 Schering Aktiengesellschaft Process for the preparation of fludarabine or fludarabine phosphate from guanosine
FR2701027B1 (fr) * 1993-02-01 1997-07-18 Warner Lambert Co Procede de synthese ameliore du 9-(beta-d-arabinofuranosyl)adenine 5'-phosphate.
DE19543052A1 (de) * 1995-11-06 1997-05-07 Schering Ag Verfahren zur Herstellung und Reinigung von Fludarabin-Phosphat und die Verwendung von sauren Ionenaustauschern im Verfahren
IT1276126B1 (it) 1995-11-14 1997-10-27 Archimica Spa Procedimento per la preparazine di 9-((2-idrossietossi)metil) guanina
CA2313486A1 (en) 1997-12-11 1999-06-17 Schering Aktiengesellschaft Purification method for producing fludarabin phosphate
US6174873B1 (en) 1998-11-04 2001-01-16 Supergen, Inc. Oral administration of adenosine analogs

Also Published As

Publication number Publication date
ES2190136T3 (es) 2003-07-16
WO1999029710A2 (de) 1999-06-17
AT8617U1 (de) 2006-10-15
SK8872000A3 (en) 2001-03-12
ATE231880T1 (de) 2003-02-15
HUP0100169A3 (en) 2002-04-29
AU739574B2 (en) 2001-10-18
JP2009040797A (ja) 2009-02-26
HK1033831A1 (en) 2001-09-28
NO20002962L (no) 2000-06-09
AU2155099A (en) 1999-06-28
CZ20002159A3 (cs) 2000-09-13
EP1047704A2 (de) 2000-11-02
NO315324B1 (no) 2003-08-18
SK283475B6 (sk) 2003-08-05
EP1047704B2 (de) 2007-11-07
PL195712B1 (pl) 2007-10-31
US6046322A (en) 2000-04-04
ES2190136T5 (es) 2008-03-01
DE29825173U1 (de) 2005-12-22
IL136283A (en) 2006-10-31
JP2001525418A (ja) 2001-12-11
US7547776B1 (en) 2009-06-16
ZA9811338B (en) 1999-06-10
WO1999029710A3 (de) 1999-09-10
DE59807096D1 (de) 2003-03-06
TW424093B (en) 2001-03-01
DK1047704T4 (da) 2008-03-25
PL341659A1 (en) 2001-04-23
NO20002962D0 (no) 2000-06-09
HUP0100169A1 (hu) 2001-11-28
IL136283A0 (en) 2001-05-20
KR100532898B1 (ko) 2005-12-05
KR20010032919A (ko) 2001-04-25
SI1047704T1 (en) 2004-02-29
EP1047704B1 (de) 2003-01-29
KR20050085937A (ko) 2005-08-29
SI1047704T2 (sl) 2008-02-29
CZ296366B6 (cs) 2006-02-15
CA2313486A1 (en) 1999-06-17
HU226997B1 (en) 2010-04-28
JP4261051B2 (ja) 2009-04-30

Similar Documents

Publication Publication Date Title
EP0780370A3 (de) Verfahren zur Herstellung von D,L-Methionin oder dessen Salzen
ZA931376B (en) Production of purified calcium carbonate.
NO994466D0 (no) Krystallinsk aminsalt av cefdinir
HK1062017A1 (en) Novel acyclic nucleoside phosphonate derivatives, salts thereof and process for the preparation of the same
DK1047704T3 (da) Fremgangsmåde til fremstilling af lithium-, kalium-, calcium- og magnesiumsalte af fludarabin-phosphat og rensningsfremgangsmåde til fremstilling af fludarabin-phosphat og fludarabin-phosphat med en renhed på mindst 99,5%
DE3571550D1 (en) Pharmaceutical preparation containing a combination of nitrendipin and enalapril and process for its preparation
GB8722455D0 (en) Sustained release fluoride & calcium composition
BR9407743A (pt) Composiçao oral de peróxido de cálcio-bicarbonato
FR2717387B1 (fr) Procédé de fabrication de comprimés à croquer à base de troxérutine, de carbonate de calcium, de phosphate de calcium, d'aspartate d'arginine, de glutamate d'arginine d'amoxicilline.
NO954630D0 (no) Kalium toverdig fosfatgjödningsmiddel med kontrollert frigivelse
DK0748795T3 (da) Substituerede benzyloxycarbonylguanidiner som inhibitorer af Na+/H+-ombytningen, fremgangsmåde til deres fremstilling, dere
EP0830325A4 (en) PROCESS FOR SLOWING THE SETTING SPEED OF MAGNESIUM PHOSPHATE CEMENTS
DK0840724T3 (da) Fremgangsmåde til fremstilling af enantiomerisk ren azetidin-2-caboxylsyre
IS4860A (is) Bætt aðferð til að framleiða enantíómerískt hreina asetidín-2-karboxýlsýru
DE69704933D1 (de) Mikroporöse kristalline metallphosphate
DK0735043T3 (da) Fremgangsmåde til fremstilling af 2-substitueret 3,3-difluorfuran
EE03934B1 (et) Enantiomeerselt rikastatud N-derivaaditud laktaamide valmistamismeetod
DK0861258T3 (da) Fremgangsmåde til fremstilling af magnesiumpyridoxal-5'-phosphatglutamat og mellemprodukter opnået derved
YU28999A (sh) Postupak za kristalisanje derivata tetrahidropiridina i dobijeni kristalni oblici
HUP9904319A2 (hu) 3-Izopropil-2,1,3-benzotiadiazin-4-on-2,2-dioxid vagy sóinak szilárd keverékei
FI973836A0 (fi) Enfasig gipsbaeddsprocess foer produktion av kaliumsalter
FR2712214B1 (fr) Procédé de cristallisation des déchets.
FR2767180B1 (fr) Procede de realisation d'un joint, notamment etanche, entre deux pieces, notamment deux tuyaux ou analogues
PL346536A1 (en) Process for the preparation of calcium hydroxyalkane sulphonates
FR2743504B3 (fr) Elements de construction tridimensionnels emboitables, procede de realisation et application a la realisation d'un puzzle